20240415 lab meeting_俐妤 | 賴亮全實驗室

索引

00:00 1.
index 1
00:26 2.
Slide 2
01:29 3.
CircRNA expression profiles in NSCLC and characterization of circACVR2A
02:28 4.
CircRNA expression profiles in NSCLC and characterization of circACVR2A
03:02 5.
Slide 5
03:05 6.
CircRNA expression profiles in NSCLC and characterization of circACVR2A
03:24 7.
Slide 5
04:15 8.
Slide 6
04:54 9.
Slide 7
06:01 10.
Slide 8
06:34 11.
Prostate Cancer (PC)
07:21 12.
Genetic Alterations and Treatment Approaches of PC
08:08 13.
Mechanism of Androgen Receptor (AR)
08:47 14.
Structure and Mechanism of Second-Generation Androgen Receptor Antagonists (SG-ARA)
09:22 15.
Prostate Cancer Resistance Mechanisms
10:05 16.
Heterogeneous Patterns of Resistance Mechanisms
10:52 17.
Biological Functions of Long Non-coding RNA (lncRNA)
11:35 18.
Slide 16
12:12 19.
IRX4-AS1 Upregulated in Prostate Cancer
13:30 20.
The Characteristic of IRX4-AS1
14:37 21.
IRX4-AS1 had Lower Protein Coding Probability
15:21 22.
Slide 20
15:48 23.
Knockdown IRX4-AS1 Inhibit Cell Proliferation
16:25 24.
Knockdown IRX4-AS1 Increased Cell Viability after SG-ARA Treatment
17:01 25.
Slide 23
17:31 26.
IRX4-AS1 has Binding Potential with AR
18:12 27.
IRX4-AS1 didn’t bind with AR
18:58 28.
IRX4-AS1 has Binding Potential with miRNA
19:47 29.
Slide 27
20:05 30.
Knockdown IRX4-AS1 Increased the Level of AR mRNA and AR Protein
21:16 31.
Knockdown IRX4-AS1 Increased the Level of Canonical Gene
21:58 32.
The Characteristic of C4-2 SG-ARA resistant
23:18 33.
The Characteristic of C4-2 SG-ARA resistant
23:34 34.
IRX4-AS1 downregulated in SG-ARA resistant cells
24:10 35.
Slide 33
24:28 36.
Slide 34
25:47 37.
Thank you for listening
26:12 38.
Slide 34
26:45 39.
Genetic Alterations and Treatment Approaches of PC
28:28 40.
Mechanism of Androgen Receptor (AR)
28:31 41.
Prostate Cancer Resistance Mechanisms
28:56 42.
Structure and Mechanism of Second-Generation Androgen Receptor Antagonists (SG-ARA)
28:56 43.
Mechanism of Androgen Receptor (AR)
28:56 44.
Genetic Alterations and Treatment Approaches of PC
28:57 45.
Prostate Cancer (PC)
28:57 46.
Slide 8
28:58 47.
Slide 7
29:00 48.
Slide 6
29:06 49.
Slide 5
29:20 50.
Slide 7
30:30 51.
Knockdown IRX4-AS1 Increased the Level of Canonical Gene
35:02 52.
IRX4-AS1 didn’t bind with AR
36:24 53.
IRX4-AS1 downregulated in SG-ARA resistant cells
38:23 54.
Slide 7
39:08 55.
Prostate Cancer (PC)
40:56 56.
** after 20240430_林俐妤seminar_V2-3.pptx

筆記 (0)

未登入或權限不足!

討論

00:00 1.
index 1
00:26 2.
Slide 2
01:29 3.
CircRNA expression profiles in NSCLC and characterization of circACVR2A
02:28 4.
CircRNA expression profiles in NSCLC and characterization of circACVR2A
03:02 5.
Slide 5
03:05 6.
CircRNA expression profiles in NSCLC and characterization of circACVR2A
03:24 7.
Slide 5
04:15 8.
Slide 6
04:54 9.
Slide 7
06:01 10.
Slide 8
06:34 11.
Prostate Cancer (PC)
07:21 12.
Genetic Alterations and Treatment Approaches of PC
08:08 13.
Mechanism of Androgen Receptor (AR)
08:47 14.
Structure and Mechanism of Second-Generation Androgen Receptor Antagonists (SG-ARA)
09:22 15.
Prostate Cancer Resistance Mechanisms
10:05 16.
Heterogeneous Patterns of Resistance Mechanisms
10:52 17.
Biological Functions of Long Non-coding RNA (lncRNA)
11:35 18.
Slide 16
12:12 19.
IRX4-AS1 Upregulated in Prostate Cancer
13:30 20.
The Characteristic of IRX4-AS1
14:37 21.
IRX4-AS1 had Lower Protein Coding Probability
15:21 22.
Slide 20
15:48 23.
Knockdown IRX4-AS1 Inhibit Cell Proliferation
16:25 24.
Knockdown IRX4-AS1 Increased Cell Viability after SG-ARA Treatment
17:01 25.
Slide 23
17:31 26.
IRX4-AS1 has Binding Potential with AR
18:12 27.
IRX4-AS1 didn’t bind with AR
18:58 28.
IRX4-AS1 has Binding Potential with miRNA
19:47 29.
Slide 27
20:05 30.
Knockdown IRX4-AS1 Increased the Level of AR mRNA and AR Protein
21:16 31.
Knockdown IRX4-AS1 Increased the Level of Canonical Gene
21:58 32.
The Characteristic of C4-2 SG-ARA resistant
23:18 33.
The Characteristic of C4-2 SG-ARA resistant
23:34 34.
IRX4-AS1 downregulated in SG-ARA resistant cells
24:10 35.
Slide 33
24:28 36.
Slide 34
25:47 37.
Thank you for listening
26:12 38.
Slide 34
26:45 39.
Genetic Alterations and Treatment Approaches of PC
28:28 40.
Mechanism of Androgen Receptor (AR)
28:31 41.
Prostate Cancer Resistance Mechanisms
28:56 42.
Structure and Mechanism of Second-Generation Androgen Receptor Antagonists (SG-ARA)
28:56 43.
Mechanism of Androgen Receptor (AR)
28:56 44.
Genetic Alterations and Treatment Approaches of PC
28:57 45.
Prostate Cancer (PC)
28:57 46.
Slide 8
28:58 47.
Slide 7
29:00 48.
Slide 6
29:06 49.
Slide 5
29:20 50.
Slide 7
30:30 51.
Knockdown IRX4-AS1 Increased the Level of Canonical Gene
35:02 52.
IRX4-AS1 didn’t bind with AR
36:24 53.
IRX4-AS1 downregulated in SG-ARA resistant cells
38:23 54.
Slide 7
39:08 55.
Prostate Cancer (PC)
40:56 56.
** after 20240430_林俐妤seminar_V2-3.pptx

分享
- 嵌入網址
- QR code

索引
筆記
討論
全螢幕

20240415 lab meeting_俐妤

長度: 41:05, 瀏覽: 214, 最近修訂: 2024-04-15

00:00 1.
index 1
00:26 2.
Slide 2
01:29 3.
CircRNA expression profiles in NSCLC and characterization of circACVR2A
02:28 4.
CircRNA expression profiles in NSCLC and characterization of circACVR2A
03:02 5.
Slide 5
03:05 6.
CircRNA expression profiles in NSCLC and characterization of circACVR2A
03:24 7.
Slide 5
04:15 8.
Slide 6
04:54 9.
Slide 7
06:01 10.
Slide 8
06:34 11.
Prostate Cancer (PC)
07:21 12.
Genetic Alterations and Treatment Approaches of PC
08:08 13.
Mechanism of Androgen Receptor (AR)
08:47 14.
Structure and Mechanism of Second-Generation Androgen Receptor Antagonists (SG-ARA)
09:22 15.
Prostate Cancer Resistance Mechanisms
10:05 16.
Heterogeneous Patterns of Resistance Mechanisms
10:52 17.
Biological Functions of Long Non-coding RNA (lncRNA)
11:35 18.
Slide 16
12:12 19.
IRX4-AS1 Upregulated in Prostate Cancer
13:30 20.
The Characteristic of IRX4-AS1
14:37 21.
IRX4-AS1 had Lower Protein Coding Probability
15:21 22.
Slide 20
15:48 23.
Knockdown IRX4-AS1 Inhibit Cell Proliferation
16:25 24.
Knockdown IRX4-AS1 Increased Cell Viability after SG-ARA Treatment
17:01 25.
Slide 23
17:31 26.
IRX4-AS1 has Binding Potential with AR
18:12 27.
IRX4-AS1 didn’t bind with AR
18:58 28.
IRX4-AS1 has Binding Potential with miRNA
19:47 29.
Slide 27
20:05 30.
Knockdown IRX4-AS1 Increased the Level of AR mRNA and AR Protein
21:16 31.
Knockdown IRX4-AS1 Increased the Level of Canonical Gene
21:58 32.
The Characteristic of C4-2 SG-ARA resistant
23:18 33.
The Characteristic of C4-2 SG-ARA resistant
23:34 34.
IRX4-AS1 downregulated in SG-ARA resistant cells
24:10 35.
Slide 33
24:28 36.
Slide 34
25:47 37.
Thank you for listening
26:12 38.
Slide 34
26:45 39.
Genetic Alterations and Treatment Approaches of PC
28:28 40.
Mechanism of Androgen Receptor (AR)
28:31 41.
Prostate Cancer Resistance Mechanisms
28:56 42.
Structure and Mechanism of Second-Generation Androgen Receptor Antagonists (SG-ARA)
28:56 43.
Mechanism of Androgen Receptor (AR)
28:56 44.
Genetic Alterations and Treatment Approaches of PC
28:57 45.
Prostate Cancer (PC)
28:57 46.
Slide 8
28:58 47.
Slide 7
29:00 48.
Slide 6
29:06 49.
Slide 5
29:20 50.
Slide 7
30:30 51.
Knockdown IRX4-AS1 Increased the Level of Canonical Gene
35:02 52.
IRX4-AS1 didn’t bind with AR
36:24 53.
IRX4-AS1 downregulated in SG-ARA resistant cells
38:23 54.
Slide 7
39:08 55.
Prostate Cancer (PC)
40:56 56.
** after 20240430_林俐妤seminar_V2-3.pptx

位置

資料夾名稱

2024

發表人

周楷軒

單位

賴亮全教授

建立

2024-04-15 09:56:47

最近修訂

2024-04-15 10:16:21

長度

41:05